Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | MET | P08581 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 13/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21644707 | 0.91 | HSP90AA1 (0.50) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL21644531 | 0.84 | HSP90AA1 (0.47) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL21644592 | 0.83 | HSP90AA1 (0.43) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL21644524 | 0.79 | CYP3A4 (0.74) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL487693 | 0.77 | CYP3A4 (0.64) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL21644535 | 0.77 | CYP3A4 (0.74) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL21644654 | 0.74 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL30779628 | 0.74 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL21644635 | 0.73 | CYP3A4 (1.00) | CYP3A4CYP2C9CYP2B6CYP2C19MET | |
| SCHEMBL21644688 | 0.73 | ALDH1A1 (0.50) | CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111164074-B | Heat shock protein 90 inhibitors | 台北医学大学 | 2024-02-02 | — | — | CN | disclosed |
| US-11479528-B2 | Heat shock protein 90 inhibitors | TAIPEI MEDICAL UNIVERSITY (TW) | 2022-10-25 | — | — | US | disclosed |
| CN-111164074-A | Heat shock protein 90 inhibitor | 台北医学大学 | 2020-05-15 | — | — | CN | disclosed |
| US-20200039923-A1 | HEAT SHOCK PROTEIN 90 INHIBITORS | TAIPEI MEDICAL UNIVERSITY (TW) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039923-A1 | HEAT SHOCK PROTEIN 90 INHIBITORS | HSP90AB1, HSP90AB2P, HSP90AA1 | CYP3A4 4066/4885CYP2C9 4003/4885CYP2B6 3999/4885 |
| US-11479528-B2 | Heat shock protein 90 inhibitors | HSP90AB1, HSP90AB2P, HSP90AA1 | CYP3A4 4066/4885CYP2C9 4003/4885CYP2B6 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.